Equities

Link Reservations Inc

LRSV:PKL

Link Reservations Inc

Actions
  • Price (USD)0.0015
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change-61.54%
  • Beta2.3802
Data delayed at least 15 minutes, as of May 01 2024 15:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Link Reservations, Inc. is engaged in developing and providing cannabidiol (CBD) oil products for animals, such as dogs, cats, and horses under the name LinkResPet. The Company's LinkResPets line of products addresses allergy and immune system support, hip and joint mobility, anxiety and comfort, and everyday health and wellness for dogs, cats, and horses. The Company's DailyLifeCBD line of products includes a hemp-based lotion and focuses to secure further varieties of non-edible and edible lifestyle products for use by people. DailyLifeCBD has also extended its range to include functional mushroom-infused products. Its CBD products for dogs focus on cancer, obesity, and skin conditions, among others. Its CBD for cats focuses on epilepsy and seizures, anxiety, cancer, inflammatory bowel disease, and health and wellness, among others. The Company’s CBD products for horses focus on equine arthritis, chronic laminitis, herd bound issues, and various other conditions.

  • Revenue in USD (TTM)0.00
  • Net income in USD-480.90k
  • Incorporated2006
  • Employees0.00
  • Location
    Link Reservations Inc400 Thames Valley Park DriveREADING RG6 1PTUnited KingdomGBR
  • Phone+44 118 380 0895
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lucy Scientific Discovery Inc16.73k-9.76m1.45m----17.81--86.41-6.34-7.210.01030.0460.0037--0.7276---215.45------49.97---58,360.55-----5.100.4615-------53.49------
Virax Biolabs Group Ltd0.00-1.71m1.45m5.00---------1.50-1.500.00-0.8568------0.00----------------0.0223-112.29-----100.00---162.50------
InMed Pharmaceuticals Inc5.49m-6.35m1.47m13.00--0.1074--0.2671-1.65-1.651.222.250.34112.8724.14---39.48-88.10-45.22-104.1938.42---115.75-1,066.116.58--0.00--279.60--57.27--29.56--
Bluejay Diagnostics Inc0.00-9.95m1.47m10.00--0.2341-----9.18-9.180.002.340.00----0.00-108.25---132.91--------------0.0059---100.00---7.07------
LadRx Corp0.00331.63k1.49m2.005.1213.844.32--0.58570.58570.000.21680.00----0.0017.58-58.97480.72-78.44------------0.00------106.96------
Bioquest Corp0.00-507.41k1.49m-----------0.0485-0.04850.00-0.04670.00-------3,483.76-----------------3.88--------64.67------
Neubase Therapeutics Inc0.00-13.73m1.52m37.00--0.1653-----7.78-7.780.002.450.00-------53.51---64.61--------------0.00--------------
CTT Pharmaceutical Holdings Inc0.00-1.67m1.54m0.00--0.8665-----0.0822-0.08220.000.03460.00-------317.2813.49-448.83304.48------------0.00-------3,454.52------
Link Reservations Inc0.00-480.90k1.59m0.00---------46.51-46.510.00-13.990.00-------246.84-----------------2.43---------22.69------
Mallinckrodt PLC1.87bn-1.67bn1.60m2.80k------0.0009-177.21-177.2094.8458.900.38291.534.77666,392.90-34.26-12.49-39.27-15.8520.7035.68-89.47-44.381.55-0.45990.603---2.53-10.31-83.00------
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
180 Life Sciences Corp0.00-19.94m1.71m4.00---------64.01-64.010.00-0.23890.00----0.00-160.06-42.39-280.99-56.41------------1.14------48.52------
Aoxing Pharmaceutical Company Inc30.11m-1.46m1.74m339.00--0.0203--0.0578-0.0192-0.01920.39510.25070.4962.322.56---2.41-14.54-7.06-35.4576.1968.51-4.85-37.690.73680.33870.6052--26.8837.20-62.49---38.80--
Ensysce Biosciences Inc2.23m-10.63m1.76m7.00------0.7913-5.28-5.280.9876-0.10260.5191--11.92318,645.70-247.32-17.68---19.42-----476.40-715.78---30.284.20---11.61--57.64------
Procyon Corp4.70m-314.48k1.77m17.00--0.7961--0.3769-0.0388-0.03880.58040.29011.401.958.58276,481.20-8.903.52-10.604.2377.6073.30-6.352.522.70--0.00---3.223.1170.44--30.98--
Data as of May 01 2024. Currency figures normalised to Link Reservations Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.